In recent news, Philip Morris Japan (PMJ) announced on its official website that it will gradually stop selling traditional IQOS heating device compatible pods.
Eleven brands from the Marlboro Heat Sticks series and ten brands from the Heats series are set to be discontinued.
Two brands of Marlboro Heat Sticks (Tropical Menthol and Bright Menthol) and seven brands of Heets (Deep Bronze, Balanced Yellow, Cool Jade, Fresh Emerald, Fresh Purple, Citrus Green, and Tropical Yellow) will be discontinued by PMJ in late January 2023 and will be immediately removed from shelves once existing stock is depleted.
Delivery of pods for other IQOS heating device models will also be completed in stages and will cease immediately after store inventory is depleted in January 2024.
Meanwhile, Philip Morris International's Japanese subsidiary is currently developing the IQOS ILUMA series and the IQOS ILUMA exclusive podTEREA and SENTIA as replacement products for the IQOS blade-type device. Among them, the first capsule product in the form of Terrier Oasis Pearl will be released starting on Monday, February 6, 2023.
Reference:
Regarding the discontinuation of the sale of blade-type IQOS cigarettes.
Starting on Monday, February 6th, 2023, the first special tobacco stick for IQOS ILUMA called "TEREA" will launch with capsule technology. The new product, called "TEREA Oasis Pearl," will be released gradually.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
